PSUF
TCRT icon

People's United Financial’s Alaunos Therapeutics TCRT Stock Holding History

People's United Financial’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4
Closed -$4K – 878
2017
Q2 		$4K Hold
4
– – ﹤0.01% 979
2017
Q1 		$4K Hold
4
– – ﹤0.01% 976
2016
Q4 		$3K Hold
4
– – ﹤0.01% 971
2016
Q3 		$3K Hold
4
– – ﹤0.01% 836
2016
Q2 		$3K Hold
4
– – ﹤0.01% 836
2016
Q1 		$4K Hold
4
– – ﹤0.01% 800
2015
Q4 		$5K Hold
4
– – ﹤0.01% 784
2015
Q3 		$5K Buy
+4
New +$6.6K ﹤0.01% 772

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

People's United Financial's TCRT Position: Q3 2017 in Review

People's United Financial sold out of Alaunos Therapeutics (TCRT) in Q3 2017, closing a stake of 4 shares — an estimated $4K sold.

People's United Financial first reported a position in TCRT in Q3 2015 and held it in 8 quarters. The position peaked at $5K in Q4 2015. 122 funds tracked by Wall St. Rank hold TCRT as of Q3 2017.

  • People's United Financial reported no remaining Alaunos Therapeutics position as of Q3 2017 after selling out during the quarter.
  • People's United Financial sold 4 Alaunos Therapeutics shares in Q3 2017, an estimated $4K.
  • People's United Financial first reported a position in Alaunos Therapeutics in Q3 2015 and held it in 8 quarters.
  • People's United Financial's Alaunos Therapeutics position peaked at $5K in Q4 2015.
  • 122 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2017.

Based on People's United Financial's 13F filing for Q3 2017, filed 13 Nov 2017.